CHRNA7 and triple-A syndrome: Furthermore, in a murine model of AAA, the activation of α7nAChRs by a cholinergic agonist prevented AAA progression by a mechanism associated with the suppression of pro-inflammatory cytokines and the inhibition of vascular smooth muscle cell pyroptosis, mediated by inflammasome 3 and thereby a reduction in MMP activity [22].